Skip to main content
. 2021 Nov 30;8:677799. doi: 10.3389/fsurg.2021.677799

Table 4.

Treatments, complications, and outcomes.

Total N = 392 AGR > 1.02 N = 179 AGR ≤ 1.02 N = 213 P-value
Treatments ( n , %)
Antibiotics alone 107 (27.3%) 51 (28.5%) 56 (26.3%) 0.194
Antibiotics combined with percutaneous drainage 204 (52.0%) 85 (47.5%) 119 (55.9%)
Antibiotics combined with surgical drainage 81 (20.7%) 43 (24%) 38 (17.8%)
Complications ( n , %)
SIRS 140 (35.7%) 51 (28.5%) 89 (41.8%) 0.006
Pleural effusion 138 (35.2%) 48 (26.8%) 90 (42.3%) 0.001
Peritoneal effusion 51 (13.0%) 15 (8.4%) 36 (16.9%) 0.012
ARDS 4 (1.0%) 2 (1.1%) 2 (0.9%) 1
Septic shock 3 (0.8%) 1 (0.6%) 2 (0.9%) 1
Spontaneous rupture of abscess 3 (0.8%) 3 (1.7%) 0 (0) 0.094
Portal venous thrombosis 3 (0.8%) 1 (0.6%) 2 (0.9%) 1
AKI 1 (0.3%) 0 (0) 1 (0.5%) 1
Outcomes (% or mean ± SD)
Time for temperature normalization (days) 7.4 ± 6.3 6.7 ± 6.2 8.0 ± 6.1 0.045
Length of hospital stay (days) 16.8 ± 9.4 15.5 ± 8.6 17.9 ± 9.9 0.009
Mortality in hospital 0 0 0 1

PLA, pyogenic liver abscess; AGR, Albumin/Globulin Ratio; SIRS, systemic inflammatory response syndrome; ARDS, acute respiratory distress syndrome; AKI, acute kidney injury. Bold values: P < 0.05.